
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : AJN 003
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : $5.0 million
Deal Type : Series A Financing
AltrixBio Raises $5 Million Series A Financing to Advance Lead Candidate into the Clinic
Details : The funding will accelerate the clinical entry of AJN 003, a first-in-class oral therapy designed to transform the treatment of type 2 diabetes and metabolic diseases.
Product Name : AJN 003
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 16, 2025
Lead Product(s) : AJN 003
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : $5.0 million
Deal Type : Series A Financing
